Inclusion and exclusion criteria
Patients with diagnosis of type 1 diabetes mellitus with age between 5 and 19 years were included. Patient being treated for medical condition such as rheumatoid arthritis, taking nephrotoxic chemotherapy or having renal disease other than that caused by diabetes, febrile disease and urinary tract infection were excluded.
Diabetes type 1 was diagnosed by typical symptoms, random blood glucose (RBG) >200 mg/dl or fasting blood glucose (FBG) ≥126 mg/dl. Diabetic ketoacidosis (DKA) was diagnosed by significant hyperglycemia (>250 mg/dl), Ketonuria or ketonemia, serum bicarbonate ≤15mg/dl and DKA associated chemical signs (e.g. dehydration, Kassmaul respiration, etc.). Serum cholesterol, serum triglycerides, HbA 1C , blood pressure was recorded.
Urine albumin execration was considered to be raised if it was 30-300 mg/24 hour on atleast three consecutive occasions. Children and adolescents were considered to have normal albuminuria if it remained <30 mg/24 hour. Normal range for HbA 1C in a non-diabetic subject was considered 3.9-6.4%.
In order to exclude patient with overt disorders of lipid metabolism (e.g. familial hypercholesterolemia), the following cut-off levels for serum lipids were defined: a) Total cholesterol <300 mg/dl b) LDL cholesterol <200 mg/dl c) HDL cholesterol >20 mg/dl.
On the basis of records two groups were formed, a group with normoalbuminuric patients and a second group of microalbuminuric patients. Factors (age of onset of diabetes, diabetes duration, age at completion of study, insulin dose, HbA 1C , cholesterol, triglyceride, systolic blood pressure, diastolic blood pressure) affecting both groups will be compared.
Chi-square test will be applied and P values will be calculated. Difference will considered significant when P <0.005.
RESULTS
During the study period 215 patients were diagnosed with type1 DM. All children presented with the polyuria and the polydipsia. Other presenting features are shown in Table 1 .
Out of 215 study cases, 43 patients (12 boys, 31 girls; 20%) had microalbuminuria (MA) in the three consecutive occasions over a period of one year. Table 2 shows that 1 out of 2 toddlers had microalbuminuria (50%), 5 out of 18 school age diabetic children had microalbuminuria (27.8%) whereas, in adolescents, 5 out of 23 had microalbuminuria (21.73%). However the difference was not statistically significant. Four boys (18.91%) and seven girls (33.33%) were found to be microalbuminuric but the difference was not statistically significant (P = 0.298). Table 2 also shows that microalbuminuria was found in (11.11%) of children with a duration of diabetes mellitus less than 5 years but the highest proportion was found when the duration was more than 10 years (33.33%). However, the difference was not statistically significant. Table 2 also shows that poor glycaemic control was associated with higher proportion of microalbuminuria.8 out of 19 cases with poor glycaemic control (42.10%) while only an 3 out of 24 (12.5%) among those with accepted glycaemic control had microalbuminuria. The difference was only statistically significant among the adolescent group (13-19 years). There was significant difference in systolic and diastolic blood pressure among diabetic children with or without MA (P = 0.033 and P = 0.024 respectively). Table 3 the mean cholesterol (177.9 ± 3.1 mg/dl) and TG (219.2 ± 91.9 mg/dl) were significantly higher (P <0.001) in group with microalbuminuria than the group with normal albuminuria [cholesterol, (142.4 ± 37.1 mg/dl) and TG, (138.1 ± 3 mg/dl)]. The dose of insulin in group with microalbuminuria was significantly higher (1.4 ± 0.71 U/kg) than the group without microalbuminuria (1.5 ± 0.137 U/kg) (P <0.001). 
DISCUSSION
Diabetes has an asymptomatic stage that may be present for upto seven years before diagnosis. 4 From this information it is obvious that we have emerging challenge in our hands.
We describe our observation in a population of 43 patients. Clinical features at presentation in our subjects were similar to those reported by Ibekwe et al. 9 except that all our subjects had polyuria and polydipsia, while polyphagia was less seen frequently. The clinical picture differed from those of Omoshalewa Ugege et al., 10 who reported polydipsia in 75% and polyphagia in only 62.5% of their subjects. A cumulative prevalence of 25.58% with microalbuminuria has been identified in participating subjects. In a study by Chaturvedi N et al. MA occurred in 41.4% of patients. 11 Groups from Australia reported prevalence rate of 6-18%. 12 The variation is wide and may be related to the degree of diabetes control as it is affected by education, socioeconomic status and influence of race/ethnicity. Improper collection and storage of urine samples may affect measured levels of microalbuminuria, as urine proteins are significantly but variably underestimated after storage at -20 degree C. 13 We found 3.1:1 ratio of girls to boys with microalbuminuria in this study was similar to Moore TH et al., 14 showing that development of microalbuminuria is accelerated in girls. But this finding is in contrast to the finding to the finding of Patel et al. 15 whose study showed that microalbuminuria was more common among males. While Zahare Razavi et al. also reported that there was no sex predelication in their study. 16 Microalbuminuria occurring in older children is found to be clinically significant, while the same in younger children may reflect functional, reversible renal changes. 17 Chae et al. 18 observed that the duration of diabetes was significantly higher in the microalbuminuria group while Basiratnia et al. 19 observed no significant correlation between the duration and microalbuminuria. Currently, IPSAD (International society of Pediatric and Adolescent Diabetes) 2009 20 recommends screening from 11 years with 2 years diabetes duration and from 9 years with 5 years duration to capture most evolving microalbuminuria in children and adolescents. Based on the above criteria 9 children would not have been diagnosed with microalbuminuria in this group. These suggest that children with diabetes are at risk of developing increased albumin excretion and this would warrant regular screening.
Development and progression of microalbuminuria is closely linked to hypertension as reported by Gross et al. 21 and Zahara et al., 16 which is similar to finding in our study. An increase in blood pressure is associated with increase in urinary albumin excretion in both adults and children. 22 There is controversy as to whether an increase in blood pressure precedes or is as a result of the development of microalbuminuria. 23 Angiotensin Converting Enzyme (ACE) inhibitors delay in progression of diabetic nephropathy by normalizing glomerular capillary pressure independent of their antihypertensive effects in hypertensive and normotensive adults with diabetes had been reported. 24 Such trials in childhood and adolescence are now urgently needed.
Diabetic Nephropathy (DN) is associated with cardiovascular disease 25 and dyslipidemia is considered as a risk factor for both condition. 26 In addition, cholesterol level increases as DN progresses and also correlate positively with the rate of fall in the glomerular filtration rate. 27 Patient with microalbuminuria had significantly higher mean cholesterol and TG levels and received higher dose of insulin as compared to patient with normal albuminuria. The above finding shows poorer glycemic control in patients with microalbuminuria suggesting that the most obvious first line treatment option is to improve glycemic control. Nonetheless, today it is well established that the process of developing atherosclerosis begins in childhood and the extent of atherosclerotic lesions in adulthood is associated with levels of traditional cardiovascular risk factors such as dyslipidemia and hypertension in early life. 28, 29 Evidence from DCCT/EDIC study demonstrates that progression of carotid intima media thickness is associated with serum lipoprotein status in type 1 DM.
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CONCLUSION
Type 1 DM is treatable, and testing is acceptable and accessible to the patients. As microalbuminuria is an early microvascular complication, it is highly recommended to screen all diabetic patients for the incidence of microalbuminuria and modifiable risk factors like dyslipidemia at the onset and then yearly assessment. Efforts need to be intensified in education of health workers and population at large for quick presentation and prompt diagnosis in order to predict overt diabetic nephropathy and also to prevent its progression.
